Elizabeth Cermak - Net Worth and Insider Trading

Elizabeth Cermak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elizabeth Cermak owns 4 companies in total, including Moleculin Biotech Inc (MBRX) , SteadyMed Ltd (STDY) , and Clarus Therapeutics Holdings Inc (CRXTQ) among others .

Click here to see the complete history of Elizabeth Cermak’s form 4 insider trades.

Insider Ownership Summary of Elizabeth Cermak

Ticker	Comapny	Transaction Date	Type of Owner
MBRX	Moleculin Biotech Inc	2020-10-02	director
STDY	SteadyMed Ltd	2018-08-30	director
CRXTQ	Clarus Therapeutics Holdings Inc	2021-12-12	director
		2021-12-12	director

Elizabeth Cermak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elizabeth Cermak Ownership Network

Ownership Network List of Elizabeth Cermak

No Data

Ownership Network Relation of Elizabeth Cermak

Elizabeth Cermak Owned Company Details

What does Moleculin Biotech Inc do?

Who are the key executives at Moleculin Biotech Inc?

Elizabeth Cermak is the director of Moleculin Biotech Inc. Other key executives at Moleculin Biotech Inc include Exec. Vice President and CFO Jonathan P. Foster , director & 10 percent owner & Chairman and Acting CEO Walter V Klemp , and 10 percent owner Waldemar Priebe .

Moleculin Biotech Inc (MBRX) Insider Trades Summary

Over the past 18 months, Elizabeth Cermak made no insider transaction in Moleculin Biotech Inc (MBRX). Other recent insider transactions involving Moleculin Biotech Inc (MBRX) include a net purchase of 188,404 shares made by Walter V Klemp , a net purchase of 28,986 shares made by Jonathan P. Foster , and a net purchase of 14,493 shares made by Robert E. George .

In summary, during the past 3 months, insiders sold 0 shares of Moleculin Biotech Inc (MBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Moleculin Biotech Inc (MBRX) were sold and 15,459 shares were bought by its insiders, resulting in a net purchase of 15,459 shares.

Moleculin Biotech Inc (MBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Moleculin Biotech Inc Insider Transactions

No Available Data

What does SteadyMed Ltd do?

Who are the key executives at SteadyMed Ltd?

Elizabeth Cermak is the director of SteadyMed Ltd. Other key executives at SteadyMed Ltd include 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp Vi Llc , and director & 10 percent owner Brian Jay Stark .

SteadyMed Ltd (STDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

SteadyMed Ltd Insider Transactions

No Available Data

What does Clarus Therapeutics Holdings Inc do?

Who are the key executives at Clarus Therapeutics Holdings Inc?

Elizabeth Cermak is the director of Clarus Therapeutics Holdings Inc. Other key executives at Clarus Therapeutics Holdings Inc include 10 percent owner Thomas Mcnerney & Partners Lp , director & Chief Executive Officer Robert E. Dudley , and Chief Commercial Officer Frank Jaeger .

Clarus Therapeutics Holdings Inc (CRXTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clarus Therapeutics Holdings Inc (CRXTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clarus Therapeutics Holdings Inc (CRXTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clarus Therapeutics Holdings Inc (CRXTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clarus Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Blue Water Acquisition Corp do?

Who are the key executives at Blue Water Acquisition Corp?

Elizabeth Cermak is the director of Blue Water Acquisition Corp. Other key executives at Blue Water Acquisition Corp include director & Chief Executive Officer Robert E. Dudley , Chief Commercial Officer Frank Jaeger , and Chief Financial Officer Richard D Peterson .

Blue Water Acquisition Corp (BLUWU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Blue Water Acquisition Corp (BLUWU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Blue Water Acquisition Corp (BLUWU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Blue Water Acquisition Corp (BLUWU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Blue Water Acquisition Corp Insider Transactions

No Available Data

Elizabeth Cermak Mailing Address

Above is the net worth, insider trading, and ownership report for Elizabeth Cermak. You might contact Elizabeth Cermak via mailing address: 1414 Raleigh Road, Suite 400, Chapel Hill Nc 27517.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.